Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis

INTRODUCTION: The Multicenter International Lymphangioleiomyomatosis (LAM) Efficacy of Sirolimus (MILES) trial revealed that sirolimus stabilised lung function in patients with moderately severe LAM. The purpose of this study was to further examine the MILES cohort for the effects of racial, demogra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Gupta, Nishant, Lee, Hye-Seung, Young, Lisa R., Strange, Charlie, Moss, Joel, Singer, Lianne G., Nakata, Koh, Barker, Alan F., Chapman, Jeffrey T., Brantly, Mark L., Stocks, James M., Brown, Kevin K., Lynch, Joseph P., Goldberg, Hilary J., Downey, Gregory P., Taveira-DaSilva, Angelo M., Krischer, Jeffrey P., Setchell, Kenneth, Trapnell, Bruce C., Inoue, Yoshikazu, McCormack, Francis X.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394189/
https://ncbi.nlm.nih.gov/pubmed/30846465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02066-2018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados